**Background**
Liver X receptors (LXRs), including the LXRβ isoform, are nuclear receptors that play a critical role in regulating lipid metabolism, cholesterol homeostasis, and inflammatory responses. By acting as sensors for oxysterols, LXRs modulate the expression of genes involved in cholesterol efflux and reverse cholesterol transport, making them essential targets for treating atherosclerosis and other metabolic disorders. Understanding the precise interaction between ligands and the LXRβ ligand-binding domain (LBD) is vital for the development of selective modulators that can minimize side effects such as hepatic steatosis. In this context, we will introduce a structural unit for the development of LXRβ modulators – LXRβ ligand 1.
**Definition**
LXRβ ligand 1 is an LXRβ ligand-binding domain agonist with an EC50 of 57 μM and a Ki of 28 μM against human LXRβ.
**Mechanism of Action**
According to the LXRβ ligand 1 description, this compound functions by binding to the LXRβ LBD and locking it into an agonist conformation. Specifically, LXRβ ligand 1 forms hydrogen bonds with His435, which stabilizes the His-Trp activation switch. Structurally, its tert-butyl moiety occupies a hydrophobic subpocket, while its phenyl moiety establishes a π-π stacking interaction with Phe329. These specific molecular interactions allow the compound to serve as a critical building block for the design of more potent LXRβ modulators.
**In Vitro Studies**
The LXRβ ligand 1 in vitro activity was evaluated using a fluorescence polarization-based competition assay. It was demonstrated that LXRβ ligand 1 (compound F3) activates purified human LXRβ-LBD to recruit coactivator peptides, exhibiting a potency of 23% relative to the reference agonist GW3965. Furthermore, the compound binds to the purified human LXRβ-LBD and stabilizes the receptor in an active conformation through a combination of specific hydrogen bonding, hydrophobic interactions, and π-π stacking. For researchers seeking detailed LXRβ ligand 1 technical information, these findings highlight its utility as a scaffold for further chemical optimization. In conclusion, LXRβ ligand 1 is an LXRβ LBD agonist that provides a structural basis for the development of selective LXRβ modulators.
Keywords
LXRβ ligand 1, 171049-41-5, LXRβ ligand1, LXRβ ligand-1, LXR, Liver X receptor, Liver X receptor β ligand binding domain, His435, co-activator peptide, Phe329, His-Trp activation switch, human LXRβ-LBD, Inhibitor, inhibitor, inhibit
References